TAKARA BIO
Takara Bio offers gene and cell therapy manufacturing and customer services. They provide technical support, sales, shipping, and delivery. Their services include vector information, online tools, partnering, and licensing.
TAKARA BIO
Industry:
Biotechnology Customer Service Delivery Shipping
Founded:
1984-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.takarabio.com
Total Employee:
101+
Status:
Active
Contact:
+1 800 662 2566
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt Amazon SSL By Default
Similar Organizations
GT Partners
GT Partners provides expense reduction and cost recovery services.
Midwest Converting
Midwest Converting provides contract converting, warehousing, distribution, and logistic services.
Southern Delivery
Southern Delivery is a provider of shipping, tracking, logistics, and delivery services for clients.
Wilcox Bodies
Wilcox Bodies is a manufacturing custom service company.
Official Site Inspections
http://www.takarabio.com Semrush global rank: 313.91 K Semrush visits lastest month: 123.26 K
- Host name: 208.115.122.177
- IP address: 208.115.122.177
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
More informations about "Takara Bio"
About Takara Bio
Additional product, intellectual property, and restricted use information is available at takarabio.com. Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, …See details»
Corporate Executives | Corporate Guide - TAKARA BIO INC.
Koichi Nakao. President&CEO. Member of the Board of Directors. Junichi Mineno. Vice President and Executive Officer. Member of the Board of Directors. Yoh HamaokaSee details»
HOME | Takara Bio Inc.
2025/02/13 Consolidated Financial Results for the Nine Months Ended December 31, 2024 (Under Japanese GAAP) （431KB）See details»
Takara Bio USA - Overview, News & Similar companies - ZoomInfo
Oct 10, 2024 An internal source in IT Management & Administration has indicated that the organization has completed initiatives related to server provisioning within the last nine …See details»
Takara Bio (TYO:4974) Company Profile & Description - Stock …
Apr 1, 2025 Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in …See details»
Takara Bio Group - TAKARA HOLDINGS INC.
Contract Development and Manufacturing Organization (CDMO) Through our CDMO business, Takara Bio provides contract services for biologics development and manufacturing, in all steps from process development to product …See details»
Corporate Guide - TAKARA BIO INC.
We aim to be a global platformer. that is responsible for the infrastructure. of the life science industry. through our Reagents/Instruments. and CDMO businesses.See details»
Takara Bio USA, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Takara Bio USA, Inc. of San Jose, CA. Get the latest business insights from Dun & Bradstreet.See details»
Takara Bio Profile | The Scientist
Nov 19, 2024 Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip NDâ„¢ Real-Time PCR System, an automated, …See details»
Takara Bio - Craft
Takara Bio (formerly Clontech Laboratories) is a company that specializes in in biochemistry tools. It provides life science reagents, kits, and services under the Takara, Cellartis, and Clontech …See details»
Message from the president | Corporate Guide | Takara Bio Inc.
Based on our corporate philosophy of "contributing to the health of humankind through the development of revolutionary biotechnologies such as gene therapy," Takara Bio Group has …See details»
Takara Bio Inc Company Profile - Overview - GlobalData
Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used …See details»
Our history - Takara Bio
Additional product, intellectual property, and restricted use information is available at takarabio.com. Takara Bio USA, Inc. provides kits, reagents, instruments, and services that …See details»
Takara Bio - PharmaSource
Takara Bio is a leading provider in the biopharmaceutical industry, specialising in contract manufacturing and research services. As a contract manufacturing organisation (CMO), …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»
New study results reinforce TAGRISSO® (osimertinib) as the …
Mar 25, 2025 New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO ® (osimertinib), as …See details»
Good science needs great people - Takara Bio
Additional product, intellectual property, and restricted use information is available at takarabio.com. Takara Bio USA, Inc. provides kits, reagents, instruments, and services that …See details»
CDMO | Business - TAKARA BIO INC.
Through our CDMO (Contract Development and Manufacturing Organization) business, Takara Bio provides contract services for biologics development and manufacturing, in all steps from …See details»
New study results reinforce Tagrisso as the backbone therapy for …
Mar 25, 2025 New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as …See details»
Takara Bio—Home
Dr. Darya Marchany-Rivera speaks about her passion for helping people—including Hispanic students—meet their goals and dreams. In our third spotlight interview for National Hispanic …See details»